Articles dans des revues avec comité de lecture (176)
  1. 35. Brachet, C., Boros, E., Tenoutasse, S., Lissens, W., Andry, G., Martin, P., Bergmann, P., & Heinrichs, C. (2009). Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager. European journal of endocrinology, 161(1), 207-210. doi:10.1530/EJE-09-0257
  2. 36. Matrane, A., Mariaule, E., Martin, P., & Bergmann, P. (2009). Hémorragie digestive basse: Apport de la scintigraphie aux hématies marquées. Revue médicale de Bruxelles, 30(1), 55-58.
  3. 37. Mesquita, M., Demulder, A., Damry, N., Melot, C., Wittersheim, E., Willems, D., Dratwa, M., & Bergmann, P. (2009). Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. Clinical chemistry and laboratory medicine, 47(3), 339-346. doi:10.1515/CCLM.2009.075
  4. 38. Bergmann, P., Body, J.-J., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Reginster, J.-Y., & Gangji, V. (2009). Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. International journal of clinical practice, 63(1), 19-26. doi:10.1111/j.1742-1241.2008.01911.x
  5. 39. Body, J.-J., Moreau, M., Bergmann, P., Paesmans, M., Dekelver, C., & Lemaire, M.-L. (2008). Prédiction du risque fracturaire absolu par validation de facteurs de risque et dépistage de l'ostéoporose dans une cohorte bruxelloise suivie pendant 10 ans (étude FRISBEE *). Revue médicale de Bruxelles, 29(4), 289-293.
  6. 40. Bergmann, P. (2008). Intérêt clinique des marqueurs biologiques du remodelage osseux dans l'ostéoporose. Revue médicale de Bruxelles, 29(4), 295-300.
  7. 41. Devogelaer, J.-P., Bergmann, P., Body, J.-J., Boutsen, Y., Goemaere, S., Kaufman, J.-M., Reginster, J.-Y., Rozenberg, S., & Boonen, S. (2008). Management of patients with Paget's disease: A consensus document of the Belgian Bone Club. Osteoporosis international, 19(8), 1109-1117. doi:10.1007/s00198-008-0629-8
  8. 42. De Wolf, N., Karmali, R., Beyer, I., & Bergmann, P. (2008). Effect of strontium on PTHrP, OPG and RANKL mRNA expression in osteoblastic like cells UMR 106.1. Journal of bone and mineral research, 23(Supplément S1), SU016, 247. doi:10.1002/jbmr.5650231305
  9. 43. Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S. G., Reginster, J.-Y., Rozenberg, S., & Kaufman, J.-M. (2007). Management of cancer treatment-induced bone loss in early breast and prostate cancer - A consensus paper of the Belgian Bone Club. Osteoporosis international, 18(11), 1439-1450. doi:10.1007/s00198-007-0439-4
  10. 44. De Wolf, N., Holy, X., Begot, L., Delree, P., Coulic, V., Karmali, R., & Bergmann, P. (2007). Decreased PTHrP mRNA expression in the periosteum of hind limb long bones in tail suspended rats. Bone, 40(2), 211.
  11. 45. Hizem, R., Delaunoy, I., Ventura, M., & Bergmann, P. (2007). Prevention of bone loss in patients with spinal cord section with weekly alendronate: A pilot study. Osteoporosis international, 18(1), 121.
  12. 46. Mesquita, M., Wittersheim, E., Damry, N., Melot, C., Demulder, A., Willems, D., Dratwa, M., & Bergmann, P. (2007). Osteoprotegerin (OPG): A link between bone disease and arterial calcifications in chronic renal failure (CRF)? Osteoporosis international, 18(1), 101.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     Suivant >>